Literature DB >> 28811268

Antecedent ADHD, dementia, and metabolic dysregulation: A U.S. based cohort analysis.

Keith Fluegge1, Kyle Fluegge2.   

Abstract

INTRODUCTION: Epidemiological and genetic studies have reported a link between antecedent ADHD and dementia. The underpinning mechanisms of these associations are not known and have generated considerable speculation.
METHODS: We have extracted hospitalization discharge data on dementia and ADHD (representing a severe phenotype) from the Healthcare Cost and Utilization Project (HCUPnet) and utilized a Poisson regression with two-ways fixed effects to investigate this association.
RESULTS: An unadjusted ten-year lagged measure of a severe ADHD phenotype increases hospitalization risk for an all-listed Lewy Body Dementia (LBD) diagnosis (IRR: 1.21, 95% C.I. 1.08-1.35) and Alzheimer's disease (AD) discharge diagnosis (IRR: 1.15, 95% C.I.: 1.05-1.27). However, these relationships may be dependent upon the extent of metabolic dysregulation in a subtype-specific manner, as controlling for diabetes removes the significant association between antecedent ADHD and risk of AD but not LBD. DISCUSSION: These results indicate that the association between antecedent ADHD and dementia risk may be uniquely influenced by metabolic dysregulation, building upon prior discussion in this journal of a purported link between AD and diabetes. We tie the current findings to environmental risk factors that we have previously implicated in the etiology of ADHD to generate testable hypotheses on the underlying brain neurochemistry that may facilitate the link between metabolic dysregulation and dementia subtype risk.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADHD; Alzheimer's disease; Diabetes; Lewy body dementia; Obesity

Mesh:

Year:  2017        PMID: 28811268     DOI: 10.1016/j.neuint.2017.08.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  10 in total

1.  Tau Protein Levels in ADHD.

Authors:  Keith Fluegge
Journal:  Indian J Clin Biochem       Date:  2018-04-19

2.  Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease.

Authors:  Sung Hyun Tag; Baeksun Kim; Jinhee Bae; Keun-A Chang; Heh-In Im
Journal:  Mol Brain       Date:  2022-06-08       Impact factor: 4.399

3.  A model of lipid dysregulation and altered nutrient status in Alzheimer's disease.

Authors:  Keith Fluegge
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-30

4.  Longitudinal Neuropsychological Assessment in Two Elderly Adults With Attention-Deficit/Hyperactivity Disorder: Case Report.

Authors:  Margarete Klein; Maria Aparecida Silva; Gabriel Okawa Belizario; Cristiana Castanho de Almeida Rocca; Antonio De Padua Serafim; Mario R Louzã
Journal:  Front Psychol       Date:  2019-05-28

5.  Contribution of vascular risk factors to the relationship between ADHD symptoms and cognition in adults and seniors.

Authors:  Brandy L Callahan; André Plamondon; Sascha Gill; Zahinoor Ismail
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

6.  Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study.

Authors:  Maja Dobrosavljevic; Le Zhang; Miguel Garcia-Argibay; Ebba Du Rietz; Henrik Andershed; Zheng Chang; Stephen Faraone; Henrik Larsson
Journal:  Eur Psychiatry       Date:  2021-12-20       Impact factor: 5.361

Review 7.  ADHD and Neurodegenerative Disease Risk: A Critical Examination of the Evidence.

Authors:  Sara Becker; Manu J Sharma; Brandy L Callahan
Journal:  Front Aging Neurosci       Date:  2022-01-25       Impact factor: 5.750

8.  Investigation of the Association Between History of Learning Disabilities and Primary Progressive Aphasia in Brazilian Portuguese Speakers.

Authors:  Talita Gallas Dos Reis; Thais Helena Machado; Paulo Caramelli; Francisco Scornavacca; Liana Lisboa Fernandez; Bárbara Costa Beber
Journal:  Front Neurol       Date:  2022-02-28       Impact factor: 4.003

Review 9.  Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.

Authors:  Cintya Nirvana Dutta; Leonardo Christov-Moore; Hernando Ombao; Pamela K Douglas
Journal:  Front Hum Neurosci       Date:  2022-09-26       Impact factor: 3.473

10.  Exploring the causal effects of genetic liability to ADHD and Autism on Alzheimer's disease.

Authors:  Panagiota Pagoni; Christina Dardani; Beate Leppert; Roxanna Korologou-Linden; George Davey Smith; Laura D Howe; Emma L Anderson; Evie Stergiakouli
Journal:  Transl Psychiatry       Date:  2022-10-01       Impact factor: 7.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.